Current Ratio in % of Entrada Therapeutics, Inc. from Q2 2022 to Q3 2025

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Entrada Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2022 to Q3 2025.
Entrada Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2025 was 1.52K %, a 329% increase year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Growth (%)

Entrada Therapeutics, Inc. Quarterly Current Ratio (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	1.52K	+1.17K	+329%	Sep 30, 2025
Q2 2025	1.13K	+847	+299%	Jun 30, 2025
Q1 2025	839	+589	+236%	Mar 31, 2025
Q4 2024	489	+225	+85.4%	Dec 31, 2024
Q3 2024	355	+48	+15.6%	Sep 30, 2024
Q2 2024	284	-117	-29.1%	Jun 30, 2024
Q1 2024	250	-292	-53.9%	Mar 31, 2024
Q4 2023	264	-997	-79.1%	Dec 31, 2023
Q3 2023	307	-1.41K	-82.1%	Sep 30, 2023
Q2 2023	400	-1.6K	-80%	Jun 30, 2023
Q1 2023	541			Mar 31, 2023
Q4 2022	1.26K			Dec 31, 2022
Q3 2022	1.72K			Sep 30, 2022
Q2 2022	2K			Jun 30, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.